Globe News Wire – Sigmoid Pharma Limited Announces a Strategic Collaboration with Dr. Falk Pharma GmBH

Please link to the article below which was posted in Apr 2017 by

Sigmoid Pharma develop innovative pharmaceuticals for gastrointestinal and immunological diseases, they have entered into an exclusive agreement with Dr. Falk Pharma GmBH advance Sigmoid’s SmPill® cyclosporine franchise in Europe. As part of the agreement Sigmoid are to receive up-front equity investment, development funding as well as clinical and operational support.

You can access further information by reading the full article by clicking on the button below.

Share This Post!

If you are interested in becoming an Investor or seeking investment, then please contact us.